| [1] |
Jiang JX, Liu Q, Mao XY, et al. Downward trend in the prevalence of Helicobacter pylori infections and corresponding frequent upper gastrointestinal diseases profile changes in Southeastern China between 2003 and 2012[J]. Springerplus, 2016, 5(1):1601.
doi: 10.1186/s40064-016-3185-2
pmid: 27652174
|
| [2] |
刘伟, 许春娣, 奚容平, 等. 上海地区不同家庭环境中儿童幽门螺杆菌感染的流行病学[J]. 中国实用儿科杂志, 2006, 21(1): 19-21.
|
| [3] |
中华医学会消化病学分会. 中国慢性胃炎共识意见(2017年, 上海)[J]. 胃肠病学, 2017, 22(11):670-687.
|
| [4] |
中华医学会消化病学分会, 中华医学会消化病学分会消化系统肿瘤协作组. 中国慢性胃炎诊治指南(2022年,上海)[J]. 中华消化杂志, 2023, 43(3):145-175.
|
| [5] |
Zullo A, Hassan C, Romiti A, et al. Follow-up of intestinal metaplasia in the stomach: When, how and why[J]. World J Gastrointest Oncol, 2012, 4(3):30-36.
doi: 10.4251/wjgo.v4.i3.30
URL
|
| [6] |
潘多, 孙思予, 刘香, 等慢性萎缩性胃炎的胃镜与病理诊断的对比分析[J]. 现代肿瘤医学, 2018, 26(6):899-902.
|
| [7] |
陈敏敏, 郑松柏, 肖立, 等. 胃窦幽门腺组织学和超微结构的增龄变化研究[J]. 中华老年医学杂志, 2014, 33(8):887-890.
|
| [8] |
Kalkan Ç, Soykan I. Differences between older and young patients with autoimmune gastritis[J]. Geriatr Gerontol Int, 2017, 17(7):1090-1095.
doi: 10.1111/ggi.12832
pmid: 27444719
|
| [9] |
Xiao S, Fan Y, Yin Z, Zhou L. Endoscopic grading of gastric atrophy on risk assessment of gastric neoplasia: A systematic review and meta-analysis[J]. J Gastroenterol Hepatol, 2021, 36(1):55-63.
doi: 10.1111/jgh.v36.1
URL
|
| [10] |
Pimentel-Nunes P, Libânio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019[J]. Endoscopy, 2019, 51(4):365-388.
doi: 10.1055/a-0859-1883
pmid: 30841008
|
| [11] |
Aumpan N, Vilaichone RK, Pornthisarn B, et al. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial)[J]. PLoS One, 2021, 16(8): e0255601.
|
| [12] |
Gaziano JM, Brotons C, Coppolecchia R, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): A randomised, double-blind, placebo-controlled trial[J]. Lancet, 2018, 392(10152):1036-1046.
doi: S0140-6736(18)31924-X
pmid: 30158069
|
| [13] |
Curtis E, Fuggle N, Shaw S, et al. Safety of cyclooxygenase-2 inhibitors in osteoarthritis: outcomes of a systematic review and meta-analysis[J]. Drugs Aging, 2019, 36(Suppl 1):25-44.
doi: 10.1007/s40266-019-00664-x
pmid: 31073922
|
| [14] |
时永全, 樊代明. 慢性萎缩性胃炎的前世、今生与未来[J]. 中华消化杂志, 2021, 41(Z1):1-5.
|
| [15] |
Mori H, Suzuki H, Matsuzaki J, et al. Development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication[J]. Ann Med, 2022, 54(1):170-180.
doi: 10.1080/07853890.2021.2024875
URL
|
| [16] |
Iino C, Shimoyama T, Chinda D, et al. Infection of helicobacter pylori and atrophic gastritis influence lactobacillus in gut microbiota in a Japanese population[J]. Front Immunol, 2018, 6(9):712.
|
| [17] |
Sung JJY, Coker OO, Chu E, et al. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication[J]. Gut, 2020, 69(9):1572-1580.
doi: 10.1136/gutjnl-2019-319826
URL
|
| [18] |
Kawamura M, Uedo N, Koike T, et al. Kyoto classification risk scoring system and endoscopic grading of gastric intestinal metaplasia for gastric cancer: Multicenter observation study in Japan[J]. Dig Endosc, 2022, 34(3):508-516.
doi: 10.1111/den.v34.3
URL
|
)
